ESR Test for Cancer: How It Helps Detect Inflammation and Cancer Risk

The erythrocyte sedimentation rate (ESR) test is a widely used, cost-effective blood test to evaluate the presence of systemic inflammation. While it is not cancer-specific, persistent elevation in ESR levels can warrant further diagnostic investigation. For pathologists and healthcare professionals, knowing how ESR levels correlate with certain cancers is imperative.

This article examines the role of the ESR test in cancer detection, outlines what constitutes high or low ESR values, and discusses how ESR levels vary in specific cancer types.

What is the ESR Test?

The ESR test measures the rate at which red blood cells (erythrocytes) settle in a vertical tube over one hour. An accelerated sedimentation rate suggests the presence of inflammation. It may be due to infection, autoimmune disorders or malignancy.

ESR is a nonspecific test, meaning it does not pinpoint the exact cause of inflammation. However, combined with clinical evaluation and other biomarkers (e.g., CRP, ferritin), it serves as a useful screening and monitoring tool.

Chronic inflammation is increasingly recognised as a contributor to cancer progression. High ESR levels are not diagnostic of cancer but can indicate the kind of inflammation. ESR can be an early clue to hidden disease and is also used to monitor response to cancer treatment or relapse during post-treatment surveillance.

ESR Test for Cancer: Clinical Relevance

Higher ESR levels can reflect the systemic inflammation often associated with cancer progression. Tumour cells produce cytokines and other inflammatory mediators that increase plasma fibrinogen and immunoglobulin levels– factors that influence erythrocyte aggregation and sedimentation rate. Research has shown that persistently high ESR values are associated with a greater risk of malignancy.

When Should Pathologists Consider ESR?

Although not specific, the ESR test is valuable in cancer diagnostics when:

• The patient presents with non-specific symptoms (e.g., weight loss, night sweats, fatigue).
• There is clinical suspicion of occult malignancy.
• Inflammatory markers are being tracked in known cancer cases.
• Post-treatment surveillance is required.

It is especially useful in combination with other laboratory and imaging studies.

ESR Level for Cancer

There is no universal ESR cutoff that signals cancer. However, certain trends have emerged in clinical practice:

ESR Level	Interpretation
20–40 mm/hr	Mild elevation; may be seen in localised inflammation or early-stage disease
40–70 mm/hr	Moderate elevation; suggests systemic inflammation, possibly malignancy or autoimmune disease
>70 mm/hr	High elevation; raises concern for advanced cancer, severe infection, or connective tissue disorders

ESR values exceeding 100 mm/hr in patients with solid tumours may suggest metastatic disease. Such high values have been observed in advanced malignancies and are associated with poor outcomes.

A significantly higher ESR level for cancer, especially when accompanied by unexplained symptoms (e.g., weight loss, fatigue, anaemia), should prompt further investigation.

ESR Level in Specific Cancers

In addition to indicating malignancy, ESR levels can also reveal the exact type of cancer. Once again, it might need further investigation.

ESR Level in Lung Cancer

Lung cancer often presents with elevated ESR values, particularly in advanced stages. Studies have found that patients with non-small cell lung cancer (NSCLC) may have ESR levels exceeding 60 mm/hr. The elevation correlates with tumour burden and metastasis.

Pathologists should consider high ESR in the presence of respiratory symptoms, especially in older patients or those with risk factors such as smoking history.

ESR Level in Colon Cancer

In colorectal cancer, ESR levels tend to increase with the tumour stage and the presence of metastasis. ESR levels over 50 mm/hr have been associated with advanced colon cancer. Elevated ESR may serve as an adjunct marker alongside carcinoembryonic antigen (CEA) levels and colonoscopy findings.

ESR testing may be particularly helpful in cases of occult gastrointestinal bleeding, where inflammation-driven neoplasms remain a possibility.

High ESR levels are also observed in:

• Lymphomas (Hodgkin's and non-Hodgkin's)
• Multiple myeloma
• Advanced breast, ovarian, and prostate cancers
• Kidney cancer, chronic lymphoid leukaemia, malignant melanoma
• Head and neck cancers

While ESR levels can vary based on the cancer type and stage, they are generally higher in aggressive or late-stage malignancies.

ESR Range for Cancer

ESR reference values can vary slightly by laboratory. Normal and abnormal ESR values may also be stratified by age and gender. Standard ESR normal ranges are as follow:

Group	Normal ESR (mm/hr)	Abnormal ESR (mm/hr) >
Women (18–50 yrs)	0–12	12
Men (18–50 yrs)	0–10	10
Women (51–60 yrs)	0–19	19
Men (51–60 yrs)	0–12	12
Women (61–70 yrs)	0–20	20
Men (61–70 yrs)	0–14	14
Women (71–100 yrs)	0–35	35
Men (71–100 yrs)	0–30	30
Children (1 yr)	0–12	12
Children (8–14 yrs)	0–17	17

In the context of cancer:

• ESR >30 mm/hr may require further assessment.
• ESR >50 mm/hr strongly suggests active disease or malignancy.
• ESR >100 mm/hr is typically associated with severe inflammation or advanced cancer.

Factors Influencing ESR in Cancer

• Tumour burden and metastasis: Larger or metastatic tumours cause more inflammation.
• Inflammatory response: The immune system's reaction to tumour growth increases ESR.
• Infections: Cancer patients are prone to infections, which can raise ESR independently.
• Coexisting conditions: Autoimmune diseases or chronic illnesses can distort ESR results.

High ESR: Causes and Treatment

In addition to malignancy, several non-cancerous conditions can cause high ESR levels:

• Rheumatoid arthritis
• Lupus (SLE)
• Chronic infections (e.g., tuberculosis)
• Kidney disease
• Anaemia

Therefore, interpreting high ESR values requires clinical correlation and should not be considered in isolation.

Treatment and Management

High ESR causes and treatment involve addressing the underlying cause. In cancer, ESR may decrease following:

• Surgical tumour removal
• Chemotherapy or radiation
• Anti-inflammatory or immunosuppressive therapy.

Also check - HRD Testing: A Crucial Tool in Cancer Diagnosis

Low ESR Symptoms and Implications

While less common, low ESR can also have a clinical interpretation. Conditions associated with abnormally low ESR include:

• Polycythemia vera
• Sickle cell anaemia
• Leukocytosis
• Hypofibrinogenemia

Symptoms of low ESR are usually linked to the underlying condition rather than the ESR itself. In cancer patients, low ESR is not common unless masked by a hematologic disorder affecting red cell morphology.

Other Diagnostic Tests Used With ESR

ESR is often paired with several tests to increase the accuracy:

• Tumor markers such as PSA, CA-125, or CEA
• Imaging studies (CT, MRI, PET)
• Cancer screening panels
• CRP and complete hemogram (CHG)

Lifestyle Tips to Manage ESR Levels

To support overall health and reduce chronic inflammation:

• Eat a balanced diet rich in vegetables, fruits, whole grains, and healthy fats.
• Limit processed foods and added sugars.
• Engage in regular physical activity.
• Manage stress through mindfulness or yoga.
• Sleep 7–9 hours nightly.
• Stay hydrated.
• Get regular health checkups and screenings.

ESR and Differential Diagnosis: Avoiding False Alarms

Given the nonspecific nature of the ESR test, false positives are common. High ESR can result from:

• Infections
• Autoimmune diseases
• Chronic kidney disease
• Ageing

Related read - CBC with ESR Test Guide

Closure

The ESR test for cancer remains a practical tool for assessing systemic inflammation and supporting cancer diagnostics. While not cancer-specific, elevated ESR levels can signal malignancy or disease progression and should prompt further evaluation. For pathologists and clinicians, integrating ESR with clinical assessment, imaging and biomarkers offers a more complete diagnostic view.

Its role in post-treatment monitoring also adds value. Use ESR as part of a broader diagnostic framework, not in isolation. Always correlate with patient history and symptoms. Stay alert to subtle trends—early detection can influence prognosis and guide timely intervention.

Also check - Lung Cancer Pathology